1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Main MR imaging signal changes and correspondent metabolic profile of MR spectroscopy during the evolution of the disease
Months after OnsetMR ImagingCho/CrNAA/CrLactateLipids
1T2 hyperintensity of the entire corpus callosum; foci of in the centrum semiovale1.351.98++–
2Unchanged1.171.67+–
4Persistent hyperintensity in the splenium and posterior half of the body of the corpus callosum; corpus callosum slightly atrophic1.061.26–+
11Slight hyperintensity of the splenium; moderate atrophy of the corpus callosum0.871.45––
Normal range0.9–1.31.8–2.4––
  • Note.—Cho indicates choline; Cr, creatine; NAA, N-acetylaspartate.